Board of Directors

Seth L. Harrison, M.D.

Chairman, Tokai Pharmaceuticals, Inc.

Managing General Partner, Apple Tree Partners

Prior Affiliations: Oak Investment Partners, Sevin Rosen Funds

Timothy J. Barberich

Prior Affiliations: Sepracor Inc., Millipore Corporation

Stephen Buckley, Jr.

Prior Affiliations: Ernst & Young LLP

Cheryl L. Cohen

President, CLC Consulting
Prior Affiliations: Medivation (Chief Commercial Officer), Johnson & Johnson, Centocor, Inc.

David A. Kessler, M.D.

Professor, University of California San Francisco
Prior Affiliations: FDA (Commissioner),Yale Medical School (Dean), University of California, San Francisco School of Medicine (Dean)

Jodie P. Morrison

President and Chief Executive Officer, Tokai Pharmaceuticals, Inc.
Prior Affiliations: Dyax Corporation, Curis, Inc. and Diacrin, Inc.

Joseph A. Yanchik III, Esq.

President and CEO, Aileron Therapeutics, Inc.
Prior Affiliations: Tokai Pharmaceuticals, Mendel Biotechnology, Poetic Genetics, Venture Law Group, Cahill Gordon & Reindel